Navigation Links
Isis Reports Financial Results and Highlights for 2012
Date:2/28/2013

red to in this press release exclude non-cash compensation expense related to equity awards. Please refer to the reconciliation of pro forma and GAAP measures, which is provided later in this release.

Revenue
Revenue for the three and twelve months ended December 31, 2012 was $19.9 million and $102.0 million, respectively, compared to $32.4 million and $99.1 million for the same periods in 2011.  Isis' revenue fluctuates based on the nature and timing of payments under agreements with Isis' partners, including license fees, milestone-related payments and other payments. For example, in 2012, Isis recognized revenue from new sources in connection with the license for ISIS-STAT3Rx which Isis granted to AstraZeneca under its recently announced strategic alliance on RNA therapeutics for cancer, its three new collaborations with Biogen Idec and the KYNAMRO FDA acceptance milestone from Genzyme. At the same time, in 2012, Isis' revenue from amortization of the upfront payments associated with the Genzyme collaboration ended as planned midyear.Isis earned a $25 million milestone payment from Genzyme in January 2013 for FDA approval of KYNAMRO and a $7.5 million milestone payment from GSK in February 2013 for the initiation of the Phase 2/3 study of ISIS-TTRRx.  Isis will reflect both of these milestone payments in its first quarter 2013 financial results.

Operating Expenses
On a pro forma basis, operating expenses for the three and twelve months ended December 31, 2012 were $44.2 million and $162.4 million, respectively, compared to $48.8 million and $160.3 million for the same periods in 2011.  In 2012, Isis was able to advance and expand its pipeline while maintaining its operating expenses essentially flat to 2011.

On a GAAP basis, Isis' operating expenses for the three and twelve months ended December 31, 2012 were $46.0 million and $171.0 million, respectively, compared to $51.0 million and
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. NxStage Reports Record Fourth Quarter and Full-Year 2012 Financial Results
2. Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results
3. Mylan Reports a 23% Increase in Fourth Quarter 2012 Adjusted Diluted EPS to $0.65
4. HeartWare International Reports Fourth Quarter 2012 Revenue Of $32.7 Million; Full Year 2012 Revenue Of $110.9 Million
5. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2012 Financial Results
6. Kewaunee Scientific Reports Improved Results for Third Quarter
7. Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
8. Questcor Reports Fourth Quarter and Full Year 2012 Results
9. ResearchMoz: Global MRI Systems Market to 2018 - Technological Advancements, Increasing Number of Applications and Advent of MRI Compatible Pacemakers to Drive Future Growth - Market Research Reports
10. United Therapeutics Corporation Reports 2012 Fourth Quarter and Annual Financial Results
11. Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... MISSION, Kan. , July 25, 2014 /PRNewswire-iReach/ ... , and TCGRx, of Powers Lake, ... exclusive partners in a distribution and co-marketing agreement ... to retail pharmacies throughout the United ... of robotics-based pharmacy management and workflow systems to ...
(Date:7/25/2014)... Trinidad and Tobago , July 25, 2014 ... the Trinidad & Tobago Ministry of Health approved ... therapy that significantly increases the cure rate from ... infected with the genotype 1 virus. Telaprevir is ... the trade brand INCIVO®. Photo - ...
(Date:7/25/2014)... July 25, 2014 According to ... "Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, ... Share, Growth, Trends and Forecast (Value and Volume), 2013 ... USD 19.99 billion in 2012 and is expected to ... 2019 to reach USD 32.24 billion in 2019. ...
Breaking Medicine Technology:ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4
... 2011 The " Global Fetal (Labor & ... global fetal and neonatal care equipment market by types and studies ... fetal and neonatal care market across 18 countries in North America, ... Explore market data tables and in-depth TOC on ...
... Incorporated (Nasdaq: VPHM ) today announced ... Pediatric Use Marketing Authorization (PUMA) for Buccolam® (midazolam, ... seizures in infants, toddlers, children and adolescents, from ... age.  This action by the European Commission represents ...
Cached Medicine Technology:MarketsandMarkets: Global Fetal and Neonatal Care Equipment Market Forecast (2011-2016) 2MarketsandMarkets: Global Fetal and Neonatal Care Equipment Market Forecast (2011-2016) 3MarketsandMarkets: Global Fetal and Neonatal Care Equipment Market Forecast (2011-2016) 4ViroPharma's Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures 2ViroPharma's Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures 3ViroPharma's Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures 4ViroPharma's Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures 5
(Date:7/26/2014)... “Today, we introduce our new items of prom ... All these models are offered at discounted prices, and ... says the CEO of the company. DressesOnlineShops.co.uk is one ... outfits. , Ladies have to find a dress solution ... the best choices for many ladies worldwide to buy ...
(Date:7/26/2014)... “Healthy teeth are important, and having your teeth cleaned regularly ... Health Center of Snohomish County (CHC) in their article, “ ... integration of medical and dental care is the best way ... encourage regular cleanings and checkups not only with a family ... adults will find knowledgeable and friendly staff that ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 Another DePuy Pinnacle ... Orthopedics, Inc., has been filed by Wright & Schulte LLC. ... on behalf of an Erie County, Ohio man who ... left hip and groin since receiving his Pinnacle Hip implant ... man will be forced to undergo a complex and risky ...
(Date:7/26/2014)... July 26, 2014 As the ... the true vision of Xoçai is ... its exclusive and healthy chocolate products. One such ... of cacao, açaí berries and blueberries, an ingredient ... high-antioxidant blend is utilized in all of Xoçai ...
(Date:7/25/2014)... 2014 Deep Research Report on Global ... is a professional and in-depth research report on ... The report provides basic Laser Scanning Confocal Microscope ... definition, classification, application, and industry chain structure as ... market analysis, including China’s domestic market as well ...
Breaking Medicine News(10 mins):Health News:Famous Supplier DressesOnlineShops.co.uk Announces Its New Selection of Prom Dresses for the UK Market 2Health News:Common Dental Care Questions Answered by Community Health Center of Snohomish County in Recent Article 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 5Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 2Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 4Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 2Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 3Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 4
... HB Litigation Conferences LLC, formerly Mealey,s Conferences, is ... Pharmaceutical Litigation 2009" on Feb. 23 at 2 ... following products: Byetta, Trasvaginal Surgical Mesh Patch, ... Product backgrounds; product liability overviews; updates on ...
... lead to better treatment for those living near sea level ... call higher altitudes home may live longer than patients residing ... Harvard researchers publishing in the Feb. 4 issue of the ... dialysis living at elevations upwards of 4,000 feet have a ...
... Commitment to Safety Net Partnerships and Quality Health ... Kaiser Permanente announced today that it ... approximately $43 million in the fourth quarter of ... Benefit grants in the fourth quarter focused on ...
... ESRX ), one of the largest pharmacy benefit management ... fourth quarter earnings,on Wednesday, February 25, 2009 after the market ... quarter results on Thursday,February 26, 2009, at 10:00 a.m. Eastern ... This call is being webcast and can be accessed at ...
... early-stage lung cancer who take part in regular physical ... a study in the February issue of the journal ... now. Patients who are more physically active report ... study shows. , "The take-home message is that ...
... 3 BD (Becton, Dickinson and Company) (NYSE: ... Meeting of Shareholders today, its shareholders approved a management ... the Board that will result in each director being ... declassify the Board at BD,s 2008 Annual Meeting of ...
Cached Medicine News:Health News:Pharmaceutical Litigation Teleconference Feb. 23 2Health News:Dialysis Patients Do Better at Higher Altitudes 2Health News:Dialysis Patients Do Better at Higher Altitudes 3Health News:Kaiser Permanente Approves $43 Million in Community Benefit Grants in Fourth Quarter 2008 2Health News:Kaiser Permanente Approves $43 Million in Community Benefit Grants in Fourth Quarter 2008 3Health News:Kaiser Permanente Approves $43 Million in Community Benefit Grants in Fourth Quarter 2008 4Health News:Express Scripts Announces Fourth Quarter 2008 Earnings Conference Call 2Health News:Regular physical activity linked to better quality of life in early-stage lung cancer survivors 2Health News:BD Announces Results of Shareholder Votes at Annual Meeting 2
... For Your Tracheostomy Care Needs, ,Each ... the latest components for efficient and convenient ... Designed by clinicians, these latex-free trays provide ... and caregiver. All of our trays also ...
... Medline Has the Right Solution For Your ... clean and care tray features the latest ... this important infection control task. Designed by ... individual needs of each patient and caregiver. ...
... provides hospitals and alternate care facilities ... care trays which offer the finest ... Designed with the guidance of experienced ... provide exactly what is required for ...
... and alternate care facilities with a ... which offer the finest in nursing ... the guidance of experienced nursing personnel, ... what is required for efficient and ...
Medicine Products: